Time period given by analyst is Intra Day when Glenmark Pharmaceuticals Ltd. price can reach defined target.
Glenmark Pharmaceuticals Ltd., incorporated in the year 1977, is a Mid Cap company (having a market cap of Rs 13956.04 Crore) operating in Pharmaceuticals sector.
Glenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the year ending 31-Mar-2021.
Financials
For the quarter ended 30-06-2021, the company reported a Consolidated Total Income of Rs 3023.54 Crore, up 5.41 % from last quarter Total Income of Rs 2868.39 Crore and up 25.81 % from last year same quarter Total Income of Rs 2403.30 Crore. Company reported net profit after tax of Rs 306.53 Crore in latest quarter.
Investment Rationale
Price breakdown below a bearish flag-like formation as it reacted lower after testing 20 days EMA
Promoter/FII Holdings
Promoters held 46.6 per cent stake in the company as of Dec 30, 2020, while FIIs held 30.2 per cent, DIIs 7 per cent and public and others 16.2 per cent.
(Disclaimer: Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.
